KR20080004531A - 스탄소포르핀 조성물 및 투여 - Google Patents

스탄소포르핀 조성물 및 투여 Download PDF

Info

Publication number
KR20080004531A
KR20080004531A KR1020077024891A KR20077024891A KR20080004531A KR 20080004531 A KR20080004531 A KR 20080004531A KR 1020077024891 A KR1020077024891 A KR 1020077024891A KR 20077024891 A KR20077024891 A KR 20077024891A KR 20080004531 A KR20080004531 A KR 20080004531A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
solution
magnesium
calcium
sodium
Prior art date
Application number
KR1020077024891A
Other languages
English (en)
Korean (ko)
Inventor
필립 씨. 랑
죠지 에스. 드럼몬드
Original Assignee
인파케어 파마슈티칼 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/096,359 external-priority patent/US20060222668A1/en
Application filed by 인파케어 파마슈티칼 코포레이션 filed Critical 인파케어 파마슈티칼 코포레이션
Publication of KR20080004531A publication Critical patent/KR20080004531A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020077024891A 2005-04-01 2006-03-31 스탄소포르핀 조성물 및 투여 KR20080004531A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11/096,359 US20060222668A1 (en) 2005-04-01 2005-04-01 Stannsoporfin compositions, drug products and methods of manufacture
US11/096,359 2005-04-01
US11/239,769 US20060222669A1 (en) 2005-04-01 2005-09-30 Stannsoporfin compositions and administration
US11/239,769 2005-09-30

Publications (1)

Publication Number Publication Date
KR20080004531A true KR20080004531A (ko) 2008-01-09

Family

ID=37073987

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077024891A KR20080004531A (ko) 2005-04-01 2006-03-31 스탄소포르핀 조성물 및 투여

Country Status (6)

Country Link
EP (1) EP1865777A4 (no)
KR (1) KR20080004531A (no)
AU (1) AU2006232330A1 (no)
CA (1) CA2602794A1 (no)
NO (1) NO20075508L (no)
WO (1) WO2006107806A2 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7375216B2 (en) 2002-06-04 2008-05-20 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin compounds
PL2079472T3 (pl) 2006-10-04 2012-01-31 Infacare Pharmaceutical Corp Wytwarzanie stannsoporfiny o wysokiej czystości na dużą skalę
DK2691398T3 (en) 2011-03-30 2017-01-16 Infacare Pharmaceutical Corp Methods for synthesizing metal mesoporphyrins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657902A (en) * 1985-03-25 1987-04-14 The Rockefeller University Therapeutic use of tin mesoporphyrin
US4692440A (en) * 1985-03-25 1987-09-08 The Rockefeller University Therapeutic use of tin mesoporphyrin
US7375216B2 (en) * 2002-06-04 2008-05-20 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin compounds
US20040097481A1 (en) * 2002-11-20 2004-05-20 Benjamin Levinson Water-soluble mesoporphyrin compounds and methods of preparation

Also Published As

Publication number Publication date
AU2006232330A1 (en) 2006-10-12
WO2006107806A3 (en) 2007-07-12
EP1865777A4 (en) 2008-07-16
CA2602794A1 (en) 2006-10-12
NO20075508L (no) 2007-10-31
EP1865777A2 (en) 2007-12-19
WO2006107806A2 (en) 2006-10-12

Similar Documents

Publication Publication Date Title
SK13742001A3 (sk) Vysokoúčinné dihydroergotamínové prostriedky
SK285650B6 (sk) Vodné prípravky moxifloxacínu a chloridu sodného,spôsob ich výroby a kombinovaný preparát
AU2002352105A1 (en) Platinum derivative pharmaceutical formulations
US8450356B2 (en) Pharmaceutical composition
US20080261939A1 (en) Stannsoporfin compositions and administration
EP2620153A1 (en) 5 alpha-androstane (alkyl)-3 beta,5,6 beta-triol injection and preparation method therefor
KR20080004531A (ko) 스탄소포르핀 조성물 및 투여
WO2012013117A1 (zh) 含维生素c或其衍生物的替莫唑胺药物组合物及其制备方法
EP1680144B1 (en) Methylphenidate solution and associated methods of administration and production
EP1166773B1 (en) Solution of N- O(p-pivaloyloxbenzenesulfonylamino)benzoyl glycine monosodium salt tetra-hydrate and drug product thereof
WO2018069805A2 (en) Method for preparation of liquid oral composition of l-thyroxin
WO2020196814A1 (en) Benzoazepine compound-containing freeze-dried composition
KR20220062368A (ko) p-보로노페닐알라닌을 함유하는 주사액제의 석출 방지 방법
JP2002080361A (ja) Ｎ−［ｏ−（ｐ−ピバロイルオキシベンゼンスルホニルアミノ）ベンゾイル］グリシン・モノナトリウム塩・４水和物含有溶液および製剤
CN114423458A (zh) 含有对二羟硼基苯丙氨酸的注射液剂
TWI619716B (zh) 含維生素ｃ或其衍生物的替莫唑胺醫藥組成物及其製備方法
EP0420193A2 (en) Use of hydroxyurea or 1-ethyl-hydroxyurea for the suppression of bone marrow cells before transplantation

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application